K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · QUEST DIAGNOSTICS INCORPORATED
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-20 | DGX | QUEST DIAGNOSTICS INCORPORATED | QUEST DIAGNOSTICS INCORPORATED | $690K | Federal policy related to strengthening the clinical laboratory workforce S. 2355 and H.R. 5582 - Patients Deserve Price Tags Act S.1816/H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 Appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing S.2761 and H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 5571 - Expanding Seniors Access to PFAS Testing Act H.R. 6130 - Alzheimers Screening and Prevention Act of 2025 Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program |
| 2026-04-20 | DGX | QUEST DIAGNOSTICS INCORPORATED | RED+BLUE STRATEGIES | $80K | Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to clinical lab test reimbursement rates. |
| 2026-04-20 | DGX | QUEST DIAGNOSTICS INCORPORATED | FEDERAL STREET STRATEGIES, LLC | $50K | Issues related to patient access and affordability of clinical laboratory testing. Issues related to the FY2026 budget and appropriations process Issues related to patient access and affordability of clinical laboratory testing. Issues related laboratory data collection and reimbursement under PAMA. H.R. 5269 - RESULTS Act S. 2761 - RESULTS Act |
| 2026-01-20 | DGX | QUEST DIAGNOSTICS INCORPORATED | QUEST DIAGNOSTICS INCORPORATED | $350K | Appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation S. 2355 and H.R. 5582 - Patients Deserve Price Tags Act S.1816/H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 Diagnostics and chronic disease prevention and treatment S.2761 and H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 5571 - Expanding Seniors Access to PFAS Testing Act Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program Regulatory changes to Sec. 216 of the Protecting Access to Medicare Act of 2014 (PAMA) |
| 2026-01-20 | DGX | QUEST DIAGNOSTICS INCORPORATED | QUEST DIAGNOSTICS INCORPORATED | $330K | Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation Federal price transparency legislation related to clinical laboratories S.1816/H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024, provisions related to Medicare reimbursement for clinical diagnostics and pathology laboratory services Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program Appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing |
| 2026-01-20 | DGX | QUEST DIAGNOSTICS INCORPORATED | QUEST DIAGNOSTICS INCORPORATED | $310K | Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation Federal price transparency legislation related to clinical laboratories S.1816/H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 H.R. 5571 - Expanding Seniors Access to PFAS Testing Act S.2761 and H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024, provisions related to Medicare reimbursement for clinical diagnostics and pathology laboratory services Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program Appropriations related to clinical laboratory workforce, PFAS and cardiovascular |
| 2026-01-20 | DGX | QUEST DIAGNOSTICS INCORPORATED | RED+BLUE STRATEGIES | $80K | Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests. |
| 2026-01-20 | DGX | QUEST DIAGNOSTICS INCORPORATED | FEDERAL STREET STRATEGIES, LLC | $50K | Issues related to patient access and affordability of clinical laboratory testing. Issues related laboratory data collection and reimbursement under PAMA. H.R. 5269 - RESULTS Act S. 2761 - RESULTS Act Issues related to patient access and affordability of clinical laboratory testing. Issues related to the FY2026 budget and appropriations process |
| 2025-10-20 | DGX | QUEST DIAGNOSTICS INCORPORATED | QUEST DIAGNOSTICS INCORPORATED | $360K | Appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation Federal price transparency legislation related to clinical laboratories S.1816/H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 H.R. 5571 - Expanding Seniors Access to PFAS Testing Act S.2761 and H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024, provisions related to Medicare reimbursement for clinical diagnostics and pathology laboratory services Federal policy related to coverage and reimbursement of clinical laboratory services under the M |
| 2025-10-20 | DGX | QUEST DIAGNOSTICS INCORPORATED | FEDERAL STREET STRATEGIES, LLC | $50K | Issues related to patient access and affordability of clinical laboratory testing. Issues related laboratory data collection and reimbursement under PAMA. H.R. 5269 - RESULTS Act S. 2761 - RESULTS Act Issues related to patient access and affordability of clinical laboratory testing. Monitor issues related to the FY2026 budget appropriations process |
| 2025-10-11 | DGX | QUEST DIAGNOSTICS INCORPORATED | RED+BLUE STRATEGIES( FORMERLY KNOWN AS NATHANSON+HAUCK) | $80K | H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting access to laboratory services for covered populations. Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. |
| 2025-07-21 | DGX | QUEST DIAGNOSTICS INCORPORATED | QUEST DIAGNOSTICS INCORPORATED | $410K | Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation Federal price transparency legislation related to clinical laboratories S.1816/H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024, provisions related to Medicare reimbursement for clinical diagnostics and pathology laboratory services Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program Appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing |
| 2025-07-21 | DGX | QUEST DIAGNOSTICS INCORPORATED | FEDERAL STREET STRATEGIES, LLC | $50K | Issues related to patient access and affordability of clinical laboratory testing. Monitor issues related to the FY2025 budget reconciliation process Issues related to patient access and affordability of clinical laboratory testing. Issues related laboratory data collection and reimbursement under PAMA. |
| 2025-07-12 | DGX | QUEST DIAGNOSTICS INCORPORATED | RED+BLUE STRATEGIES( FORMERLY KNOWN AS NATHANSON+HAUCK) | $80K | H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting access to laboratory services for covered populations. Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. |
| 2025-04-21 | DGX | QUEST DIAGNOSTICS INCORPORATED | QUEST DIAGNOSTICS INCORPORATED | $410K | Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024, provisions related to Medicare reimbursement for clinical diagnostics and pathology laboratory services Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program FY 2026 appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing |
| 2025-04-21 | DGX | QUEST DIAGNOSTICS INCORPORATED | FEDERAL STREET STRATEGIES, LLC | $50K | Issues related to patient access and affordability of clinical laboratory testing. Issues related to patient access and affordability of clinical laboratory testing. Issues related laboratory data collection and reimbursement under PAMA. |
| 2025-04-05 | DGX | QUEST DIAGNOSTICS INCORPORATED | NATHANSON+HAUCK | $80K | H.R. 1968 - Full Year Continuing Resolution - Issues related to funding within the Department of Health and Human Services and its agencies,such as CMS. Policies, rules and regulations related to clinical laboratories and Medicare coverage policies. H.R. 1968 - Full Year Continuing Resolution - Issues related to funding within the Department of Health and Human Services and its agencies,such as CMS. S. 891 - The Bipartisan Health Care Act - Issues related to Medicaid policies impacting oral health care. Policies, rules and regulations related to Medicare coverage of clinical laboratories and their services. |
| 2025-01-21 | DGX | QUEST DIAGNOSTICS INCORPORATED | QUEST DIAGNOSTICS INCORPORATED | $390K | Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship H.R. 9849 - Medical Laboratory Personnel Shortage Relief Act of 2024 H.R. 3248 - Diagnostic Lab Testing Transparency Act H.R. 5378 - Lower Costs, More Transparency Act H.R. 2369 - the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 H.R. 88188 - American Privacy Rights Act of 2024 Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation CMS policies related to Medicare Advantage Engagement with executive branch departments/agencies regarding influenza A (H5) "Avian Flu" P.L. 118-83/H.R. 9747- Continuing Appropriations and Extensions Act, 2025 , provisions related to Medicare reimbursement for clinical diagnostics laboratory services H.R. 2377/S. 1000 - Saving Access to Laboratory Services Act, provisions related to Medicare reimbursement for clinical diagnostics laboratory services P.L. 118-22/H.R. 636 |
| 2025-01-21 | DGX | QUEST DIAGNOSTICS INCORPORATED | FEDERAL STREET STRATEGIES, LLC | $50K | Issues related to patient access and affordability of clinical laboratory testing. Issues related to patient access and affordability of clinical laboratory testing. Issues related laboratory data collection and reimbursement under PAMA. H.R.1835 - Saving Access to Laboratory Services Act S.1000 - Saving Access to Laboratory Services Act |